Rznomics Inc. is a biotech company founded by Professor Seong-Wook Lee at Dankook University in August 2017. Rznomics develops RNA based gene therapies for cancers and intractable diseases. The excellence of the Rznomics’ technology has been acknowledged for being selected as a national new drug development project organized by the Ministry of Health and Welfare, TIPS program organized by the Small and Medium Business Administration, and innovative new drug pipeline discovery project organized by the Ministry of Science and ICT.

RNA replacement enzyme : Specific targeting of disease-related RNA / Multi-function of one molecule / Regulation of therapeutic gene expression / Maintenance of expression level / High Performance / Modular Engineering / Gene editing at RNA level Circular RNA : Circular RNA formation by Self-Targeting & Splicing (STS) Reaction (Any target sequences: 5’-NNNNNU-3’ in GOI) / Self-circularization can be completed during IVT / Avoids leaving unwanted sequences/structures (e.g. intronic scar) in the circRNA / Options for optimization of self-circularization efficiency (Target site screening, Optimization of P1/P10 & AS/ABS)

Private

Biotech